Our law firm has taken on the Zantac cancer litigation after the U.S. Food and Drug Administration (FDA) announced that it is investigating Zantac cancer risks after testing of certain Zantac (ranitidine hydrochloride) tablets found the commonly-used heartburn medication contains a cancer-causing chemical up to 3,000 times greater than the FDA’s daily intake limit. The carcinogenic chemical present in Zantac is known as N-nitrosodimethylamine (“NDMA”).
Learn more here: https://www.wisnerbaum.com/blog/2022/september/zantac-cancer-lawyers-file-lawsuits-for-over-7-0/
We also continue to handle commercial transportation accidents involving aviation, boat, bus, Lyft, train, truck and Uber accidents, as well as litigation involving class actions, pharmaceutical product liability, agricultural mass torts and whistleblower claims.